KSCP shows massive dilution with Class A shares increasing 143% while operating cash flow deteriorated 35% to -$30.3M despite significant capital raising.
The company raised substantial capital (cash up 85% to $20.6M, equity up 76% to $27.8M) but at the cost of extreme shareholder dilution, with outstanding Class A shares jumping from 6.5M to 15.9M shares. Despite this capital infusion, operating cash burn worsened significantly, and the company removed its core mission statement language about making America safer, suggesting potential strategic uncertainty during a critical growth phase.
KSCP's financials reflect a capital-intensive growth company burning through cash at an accelerating rate, with operating cash flow deteriorating from -$22.5M to -$30.3M while R&D spending surged 77% to $12.5M. The company successfully raised capital as evidenced by the 85% increase in cash and 76% growth in stockholders' equity, but this came with massive dilution as Class A shares outstanding increased 143%. While assets grew 46% and the balance sheet strengthened, the widening gross losses and increased cash burn signal mounting operational challenges despite the influx of new funding.
Capital expenditure jumped 1420.9% — major investment cycle underway; assess returns on deployment.
Cash position surged 84.9% — strong cash generation or capital raise providing significant financial cushion.
R&D investment increased 76.8% — signals commitment to future product development, though near-term margin impact.
Equity base grew 75.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets grew 74.7% — improving short-term liquidity or inventory/receivables build.
Asset base grew 46.4% — expansion through organic growth, acquisitions, or capital deployment.
Operating cash flow fell 35.1% — earnings quality concerns; investigate working capital changes and non-cash items.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Inventory built 29% — monitor whether demand supports this build or if write-downs may follow.
Receivables grew 23.7% — monitor days sales outstanding for collection efficiency.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →